SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-00-013866
Filing Date
2000-03-28
Accepted
2000-03-28 00:00:00
Documents
16
Period of Report
1999-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K 10-K 239109
2 EXHIBIT 4.1 EX-4.1 155979
3 EXHIBIT 10.4 EX-10.4 36141
4 EXHIBIT 10.5 EX-10.5 4915
5 EXHIBIT 10.6 EX-10.6 10296
6 EXHIBIT 10.14 EX-10.14 46783
7 EXHIBIT 10.15 EX-10.15 56174
8 EXHIBIT 10.16 EX-10.16 71440
9 EXHIBIT 10.17 EX-10.17 55429
10 EXHIBIT 10.18 EX-10.18 60548
11 EXHIBIT 10.19 EX-10.19 72035
12 EXHIBIT 10.20 EX-10.20 86464
13 EXHIBIT 10.21 EX-10.21 43438
14 EXHIBIT 21 EX-21 302
15 EXHIBIT 23 EX-23 828
16 EXHIBIT 27 EX-27 2406
  Complete submission text file 0000912057-00-013866.txt   945149
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02194-2725 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 580285
SIC: 2835 In Vitro & In Vivo Diagnostic Substances